Poland· PL-100188437
Celebrex
A celecoxib product containing celecoxibum, registered in Poland by Viatris Healthcare Limited. The same ATC class is registered in 13 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Celecoxib is registered in 13 of 19 countries.
Countries holding a registration under ATC M01AH01 (celecoxib), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 9 of them publish a price we can compare per daily dose
Celecoxib · ATC M01AH01
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Statesprice
Price per daily dose
What a daily dose of celecoxib costs, country by country.
Normalised to the WHO defined daily dose (0.2 g), the median price runs from $0.40 in Italy to $1.31 in Switzerland — a ×3.3 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Celecoxib · price per daily dose (0.2 g)
USD · FX 28 Sept 2026
- CH Switzerland$1.31
- ES Spain$0.85
- IT Italy$0.40
The record
At a glance
URPL (Poland)- Active substance
- Celecoxibum
- Manufacturer
- Viatris Healthcare Limited
- Country
- Poland (PL)
- ATC code
- M01AH01
- ATC class
- Celecoxib
- Defined daily dose
- 0.2 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909990470426
- gtin05909990470419
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
778 interactions on record for celecoxib.
Graded by severity as the source publishes them — 36 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Celecoxib · interactions on record
778 records
- 36 severe
- 349 moderate
- 4 minor
- 360 info
Most severe, free to view
- EliglustatA16AX10severe
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- CimetidineA02BA01moderate
29 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Celecoxib in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesCELEBREXViatris Specialty LLC
- CzechiaACLEXAKrka, d.d., Novo mesto, Novo mesto
- SpainARTILOG 200 mg CAPSULAS DURASViatris Healthcare Limited
- United KingdomCelebrex 200mg capsulesWaymade Healthcare Plc
- SwitzerlandCelebrex
- ItalyCELARTROXS.F. GROUP S.R.L.
- CanadaAG-CELECOXIBANGITA PHARMA INC.
- FranceCELEBREX 200 mg, géluleVIATRIS UP
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Celebrex, Celecoxib Ratiopharm
- Belgium · Celebrex, Celecoxib Ab
- Bulgaria · Аклекса, Дефинакс
- Cyprus · Celebrex, Celecoxib Accord
- Czechia · Aclexa, Celebrex
- Germany · Celebrex, Celecaxiro
- Denmark · Celebra, Celecoxib Accord
- Estonia · Aclexa, Celebrex
- Spain · Artilog, Axatal
- Finland · Celebra, Celecoxib Krka
- France · Celebrex, Celecoxib Arrow Lab
- United Kingdom (Northern Ireland) · Celebrex, Celecoxib
- Greece · Celebrex
- Croatia · Aclexa, Celixib
- Hungary · Aclexa, Celebrex
- Ireland · Celebrex, Celecoxib Accord Healthcare Ireland
- Iceland · Celebra, Celecoxib Actavis
- Italy · Celartrox, Celebrex
- Lithuania · Aclexa, Celecoxib Accord
- Luxembourg · Celebrex, Celecoxib Eg
- Latvia · Celebrex, Celecoxib Inteli
- Malta · Aclexa, Celebrex
- Netherlands · Bixocel, Celebrex
- Norway · Celebra, Celecoxib Accord
- Portugal · Celebrex, Celecoxib Alter
- Romania · Aclexa, Capsule Teva
- Sweden · Celebra, Celecoxib Accord
- Slovenia · Aclexa, Celebrex
- Slovakia · Aclexa, Celebrex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ac01cd2d-fb8f-4e5d-824e-5b62e8e2d170 GET /v1/drugs/ac01cd2d-fb8f-4e5d-824e-5b62e8e2d170?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Kapsułki",
"source": "urpl",
"strength": "200 mg",
"packaging": "05909990470426 ¦ Rp ¦ 15188\n30 kaps.\n05909990470419 ¦ Rp ¦ 39709\n10 kaps.",
"substance": "Celecoxibum 200 mg",
"common_name": "Celecoxibum",
"pl_product_id": "100188437",
"pozwolenie_nr": "04704",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about celecoxib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.